The role of immune checkpoint inhibitors (ICI) in the treatment of metastatic non-small cell lung carcinoma in the elderly

被引：2
|
作者：
Chan, Johan [1 ]
Kanesvaran, Ravindran [1 ]
机构：
[1] Natl Canc Ctr Singapore, 11 Hosp Dr, Singapore 169610, Singapore
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
关键词：
DECISION-MAKING; POOLED ANALYSIS; OPEN-LABEL; DOCETAXEL; PEMBROLIZUMAB; ATEZOLIZUMAB; CHEMOTHERAPY; MULTICENTER; NIVOLUMAB; AGE;
D O I：
10.21037/atm.2019.12.76
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors: Significant advancements in non-small cell lung cancer treatment
    Glode, Ashley E.
    May, Megan B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (09) : 769 - 780
  • [2] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [3] Immune checkpoint inhibitors for the treatment of non-small cell lung cancer: The regulatory journey in Brazil
    da Veiga, Cassia Rita Pereira
    da Veiga, Claudimar Pereira
    Machado, Erika
    Drummond-Lage, Ana Paula
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 192
  • [4] The role of checkpoint inhibitors immunotherapy in advanced non-small cell lung cancer in the elderly
    Sgambato, Assunta
    Casaluce, Francesca
    Gridelli, Cesare
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (05) : 565 - 571
  • [5] The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
    Nicos, Marcin
    Krawczyk, Pawel
    Crosetto, Nicola
    Milanowski, Janusz
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer
    Kuo, Chih-Hsi Scott
    Wang, Chin-Chou
    Huang, Yu-Chen
    Pavlidis, Stelios
    Liu, Chien-Ying
    Ko, How-Wen
    Chung, Fu-Tsai
    Lin, Tin-Yu
    Wang, Chih-Liang
    Guo, Yi-Ke
    Yang, Cheng-Ta
    THORACIC CANCER, 2019, 10 (05) : 1158 - 1166
  • [7] Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer
    Bote, Helena
    Mesas, Andres
    Baena, Javier
    Herrera, Mercedes
    Paz-Ares, Luis
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (03) : 289 - 300
  • [8] Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
    Qiu, Zhenbin
    Chen, Zihao
    Zhang, Chao
    Zhong, Wenzhao
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [9] Immune checkpoint pathways in non-small cell lung cancer
    Chae, Young Kwang
    Arya, Ayush
    Iams, Wade
    Cruz, Marcello
    Mohindra, Nisha
    Villaflor, Victoria
    Giles, Francis J.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (05)
  • [10] Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung Cancer
    Rossi, Sabrina
    Masini, Silvia
    Finocchiaro, Giovanna
    Lorenzi, Elena
    Toschi, Luca
    Santoro, Armando
    CANCERS, 2024, 16 (09)
12345